• Something wrong with this record ?

Stabilization of a DNA aptamer by ligand binding

T. Santos, J. Lopes-Nunes, D. Alexandre, A. Miranda, J. Figueiredo, MS. Silva, JL. Mergny, C. Cruz

. 2022 ; 200 (-) : 8-18. [pub] 20220510

Language English Country France

Document type Journal Article

G-rich aptamers such as AS1411 are small oligonucleotides that present several benefits comparatively to monoclonal antibodies, since they are easier to manufacture and store, have small size and do not stimulate an immune response. We analyzed AT11-B1, a modified sequence of AT11 (itself a modified version of AS1411), in which one thymine was removed from the bulge region. We studied G-quadruplex (G4) formation/stabilization using PhenDC3, PDS, BRACO-19, TMPyP4 and 360A ligands by different biophysical techniques, namely circular dichroism (CD), Förster resonance energy transfer (FRET-melting) and nuclear magnetic resonance (NMR). The CD spectra showed that AT11-B1 adopts a predominant G4 of parallel topology when the buffer contains KCl or when ligands are added. PhenDC3 induced a ΔTm of 30 °C or more of the G4 structure as shown by CD- and FRET-melting experiments. The ligands demonstrate high affinity for AT11-B1 G4 and the NMR studies revealed that the AT11-B1 G4 involves four G-tetrad layers. The in silico studies suggest that all ligands bind AT11-B1 G4, namely, by stacking interactions, with the possible exception of PDS that may bind to the loop/groove interface. In addition, molecular dynamics simulations revealed that nucleolin (NCL) interacts with the AT11-B1 G4 structure through the RNA binding domain (RBD) 2 and the 12-residue linker between RBD1,2. Moreover, AT11-B1 G4 was internalized into a NCL-positive tongue squamous cell carcinoma cell line. In a nutshell, this study may help the identification of the ligands scaffolds to bind and stabilize AT11-B1, improving the targeting towards NCL that is overexpressed in cancer cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024513
003      
CZ-PrNML
005      
20221031100322.0
007      
ta
008      
221017s2022 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biochi.2022.05.002 $2 doi
035    __
$a (PubMed)35550917
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Santos, Tiago $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
245    10
$a Stabilization of a DNA aptamer by ligand binding / $c T. Santos, J. Lopes-Nunes, D. Alexandre, A. Miranda, J. Figueiredo, MS. Silva, JL. Mergny, C. Cruz
520    9_
$a G-rich aptamers such as AS1411 are small oligonucleotides that present several benefits comparatively to monoclonal antibodies, since they are easier to manufacture and store, have small size and do not stimulate an immune response. We analyzed AT11-B1, a modified sequence of AT11 (itself a modified version of AS1411), in which one thymine was removed from the bulge region. We studied G-quadruplex (G4) formation/stabilization using PhenDC3, PDS, BRACO-19, TMPyP4 and 360A ligands by different biophysical techniques, namely circular dichroism (CD), Förster resonance energy transfer (FRET-melting) and nuclear magnetic resonance (NMR). The CD spectra showed that AT11-B1 adopts a predominant G4 of parallel topology when the buffer contains KCl or when ligands are added. PhenDC3 induced a ΔTm of 30 °C or more of the G4 structure as shown by CD- and FRET-melting experiments. The ligands demonstrate high affinity for AT11-B1 G4 and the NMR studies revealed that the AT11-B1 G4 involves four G-tetrad layers. The in silico studies suggest that all ligands bind AT11-B1 G4, namely, by stacking interactions, with the possible exception of PDS that may bind to the loop/groove interface. In addition, molecular dynamics simulations revealed that nucleolin (NCL) interacts with the AT11-B1 G4 structure through the RNA binding domain (RBD) 2 and the 12-residue linker between RBD1,2. Moreover, AT11-B1 G4 was internalized into a NCL-positive tongue squamous cell carcinoma cell line. In a nutshell, this study may help the identification of the ligands scaffolds to bind and stabilize AT11-B1, improving the targeting towards NCL that is overexpressed in cancer cells.
650    12
$a aptamery nukleotidové $x chemie $7 D052157
650    12
$a spinocelulární karcinom $7 D002294
650    12
$a G-kvadruplexy $7 D054856
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    12
$a nádory jazyka $7 D014062
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lopes-Nunes, Jéssica $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
700    1_
$a Alexandre, Daniela $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
700    1_
$a Miranda, André $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
700    1_
$a Figueiredo, Joana $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
700    1_
$a Silva, Micael S $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal
700    1_
$a Mergny, Jean-Louis $u Institute of Biophysics of the CAS, v.v.i, Královopolská 135, 612 65, Brno, Czech Republic; Laboratoire d'Optique et Biosciences, Ecole Polytechnique, CNRS, INSERM, Institut Polytechnique de Paris, 91128, Palaiseau, France
700    1_
$a Cruz, Carla $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, Covilhã, Portugal. Electronic address: carlacruz@fcsaude.ubi.pt
773    0_
$w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 200, č. - (2022), s. 8-18
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35550917 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100320 $b ABA008
999    __
$a ok $b bmc $g 1854306 $s 1175803
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 200 $c - $d 8-18 $e 20220510 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...